Patents by Inventor Yeong-Woo Jo

Yeong-Woo Jo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for treating or preventing neuropsychiatric disease, containing flavone-6-C-glucose derivatives as active ingredients
    Patent number: 10251902
    Abstract: The present invention provides a pharmaceutical composition or a food composition comprising, as active ingredients, flavone-6-C-glucose derivatives or galenical extracts containing flavone-6-C-glucose derivatives. The composition of the present invention shows a functional effect of effectively treating or preventing cognitive dysfunction disorders such as delirium, dementia or amnesia, stroke, palsy, attention disorders, anxiety disorders or sleep disorders.
    Type: Grant
    Filed: August 14, 2014
    Date of Patent: April 9, 2019
    Assignee: DAE HWA PHARMA CO., LTD.
    Inventors: Jong Hoon Ryu, Jae Hoon Cheong, Chan Young Shin, Dae Sik Jang, Hyung Eun Lee, Hyun Ji Kim, Byeol Ryu, In Ho Jung, Yeong Woo Jo
  • Three-branched polyethylene glycol-G-CSF conjugate
    Patent number: 8329191
    Abstract: The present invention relates to three-branched PEG-G-CSF conjugate of general formula (1) in which the bonding ratio of three-branched polyethylene glycol (PEG) and G-CSF is 1:1 (mol/mol), wherein PEG has an average molecular weight of from 200 to 45,000 daltons; a pharmaceutical composition comprising the same, and a preparing method thereof.
    Type: Grant
    Filed: November 22, 2006
    Date of Patent: December 11, 2012
    Assignee: Dong-A-Pharm. Co., Ltd.
    Inventors: Yeong-Woo Jo, Won-Young Yoo, Hyun-Kyu Jeon, Yun-Kyu Choi, Hye-In Jang, Byong-Moon Kim, Sung-Hee Lee, Soo-Hyung Kang, Moo-Hi Yoo
  • POLYETHYLENE GLYCOL-G-CSF CONJUGATE
    Publication number: 20100105616
    Abstract: The present invention relates to three-branched PEG-G-CSF conjugate of general formula (1) in which the bonding ratio of three-branched polyethylene glycol (PEG) and G-CSF is 1:1 (mol/mol), wherein PEG has an average molecular weight of from 200 to 45,000 daltons; a pharmaceutical composition comprising the same, and a preparing method thereof.
    Type: Application
    Filed: November 22, 2006
    Publication date: April 29, 2010
    Applicant: DONG-A PHARM. CO., LTD.
    Inventors: Yeong-Woo Jo, Won-Young Yoo, Hyun-Kyu Jeon, Yun-kyu Choi, Hye-In Jang, Byong-Moon Kim, Sung-Hee Lee, Soo-Hyung Kang, Moo-Hi Yoo
  • POLYETHYLENE GLYCOL-INTERFERON ALPHA CONJUGATE
    Publication number: 20090117077
    Abstract: The present invention relates to three-branched polyethylene glycol-interferon alpha conjugate of general formula (1) wherein polyethylene glycol has an average molecular weight of from 400 to 45,000 daltons, and a pharmaceutical composition comprising the same. The bioactive polyethylene glycol-interferon alpha conjugate of general formula (1) has antiviral and antitumoral activities, improved yield and purity by high reactivity in the reaction, and the effects to increase the half-life in blood remarkably, and to minimize the decreases in biological activity of interferon.
    Type: Application
    Filed: May 12, 2006
    Publication date: May 7, 2009
    Applicant: DONG-A PHARM. CO., LTD.
    Inventors: Yeong-Woo Jo, Won-Young Yoo, Hyun-Kyu Jeon, Yun-Kyu Choi, Hye-In Jang, Byong-Moon Kim, Sung-Hee Lee, Soo-Hyung Kang